Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levocetirizine in Pediatric Allergic Asthma
NCT04699604Phase 3Completed
- Start
- Apr 2021
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levocetirizine in allergic asthma. Started Apr 2021; status: completed.
02
Drugs
levocetirizine
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT04699604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04699604.